Roche registers giredestrant Phase 3 trial; six other studies updateNov 6Weekly roundup, 16 itemsAbbViealectinibUpdated
Emergent BioSolutions cuts 2026 revenue and EBITDA guidance as Q3 sales fall 52%Nov 2Quarterly updateAmgenAprea Therapeutics
Lilly-linked brain metastases trial posts results; two baricitinib studies completeOct 30Weekly roundup, 4 itemsabemaciclibadagrasibUpdated
Genentech gets two ROZLYTREK label updates; Roche's IMvigor011, forimtamig results standOct 2Weekly roundup, 13 itemsafimkibartatezolizumabUpdated
Sign inSign in